Rasmussen urges Europe-wide defence coalition including Ukraine ahead of Berlin talks
A former NATO secretary general has called for a new coalition of willing European states, including Ukraine, to help defend the continent if the United States reduces its military presence. Anders Fogh Rasmussen said the idea should be considered as Europe prepares for a meeting of leading defence powers in Berlin and a NATO summit in Ankara. He argued that the proposal would act as an insurance force if European allies are not ready to fill any gap left by a US drawdown.Rasmussen said the force should be led by France and the United Kingdom, which he described as Europe's... [Continue Reading]
360LiveNews | 24 Jun 2026 12:33 LONDON
Sponsored
Zelenskyy to skip Ukraine recovery conference in Poland amid tensions with Warsaw
Ukraine's president will not attend a major conference on the postwar reconstruction of his country, as a dispute with Poland continues to overshadow the gathering. The Ukraine Recovery Conference is due to open in the Polish coastal city of Gdańsk, and Ukraine's delegation will instead be led by Prime Minister Yulia Svyrydenko. The annual meeting is intended to bring together governments, partners and businesses involved in rebuilding Ukraine after the war.The latest tension follows Zelenskyy's decision last month to name a military unit after the heroes of the Ukrainian Insurgent Army, or UPA, a nationalist force that emerged from the... [Continue Reading]
360LiveNews | 24 Jun 2026 10:31 LONDON
US launches Section 301 probe into Germany's pharma pricing policies
The United States has opened a trade investigation into Germany's pharmaceutical pricing policies, raising the prospect of new tariffs on a major European economy. The move was announced on Thursday and is being carried out under Section 301 of the Trade Act of 1974. It focuses on whether Germany's pricing practices for innovative medicines unfairly burden US commerce.According to the US Trade Representative's office, the probe will examine whether Germany's approach amounts to persistent underpayment for innovative pharmaceutical products that is unreasonable or discriminatory. The notice said evidence indicates Germany uses unfair pricing policies and practices in relation to innovative... [Continue Reading]
360LiveNews | 19 Jun 2026 04:33 LONDON
